Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene
- 1 January 2004
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 14 (1) , 10-18
- https://doi.org/10.1016/s0960-8966(03)00169-x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?Neuromuscular Disorders, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Molecular pathophysiology and targeted therapeutics for muscular dystrophyTrends in Pharmacological Sciences, 2001
- Pre-mRNA splicing in the new millenniumCurrent Opinion in Cell Biology, 2001
- Analysis of canonical and non-canonical splice sites in mammalian genomesNucleic Acids Research, 2000
- Alternative pre-mRNA splicing: the logic of combinatorial controlTrends in Biochemical Sciences, 2000
- Diagnostic Protein Expression in Human Muscle BiopsiesBrain Pathology, 2000
- Multiplex Western Blotting System for the Analysis of Muscular Dystrophy ProteinsThe American Journal of Pathology, 1999
- The structural and functional diversity of dystrophinNature Genetics, 1993
- [16] Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome projectPublished by Elsevier ,1990